Jacobio Pharmaceuticals forecasts H1 net profit at least RMB 600 millionPUBT·Aug 10 at 06:53 AM01167-0.47%AZN-0.79%
Transthera wins China NMPA clearance for Phase II TT-00973 combo trial in EGFR-mutant NSCLCPUBT·Jul 10 at 09:18 AM688578+0.03%
